Other Income & Expense
Sublease Income
Vertex Pharmaceuticals Sublease Income remained flat by 0.0% to $50.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 87.5%, from $400.00K to $50.00K. Over 2 years (FY 2023 to FY 2025), Sublease Income shows a downward trend with a -72.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
How to read this metric
Higher income indicates effective asset utilization and potential cost recovery from surplus capacity.
Detailed definition
Revenue generated by leasing out portions of owned or leased assets to third-party tenants. This represents a recovery o...
Peer comparison
Often seen in companies with significant real estate holdings or excess equipment capacity.
Metric ID:
ibm_sublease_incomeHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $2.70M | $1.60M | $200.00K |
| YoY Change | — | -40.7% | -87.5% |
Range$200.00K – $2.70M
CAGR-72.8%
Avg YoY Growth-64.1%
Median YoY Growth-64.1%
Current Streak2+ years decline
Sublease Income at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's sublease income?
- Vertex Pharmaceuticals (VRTX) reported sublease income of $50.00K in Q4 2025.
- How has Vertex Pharmaceuticals's sublease income changed year-over-year?
- Vertex Pharmaceuticals's sublease income decreased by 87.5% year-over-year, from $400.00K to $50.00K.
- What is the long-term trend for Vertex Pharmaceuticals's sublease income?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's sublease income has grown at a -72.8% compound annual growth rate (CAGR), from $2.70M to $200.00K.
- What does sublease income mean?
- Income earned from renting out leased or owned assets to others.